Top accelerator startups

14,448 startups · 29 programs

Delineate

Active · Agents for Accelerated Clinical Trial Design

11signal of 100 · rising 7
  • team of 20Team size · YC's directory+6.9
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W25 in AI

All of W25

Founders

  • Emily NievesFounder/CEO
  • Jawad IqbalFounder/CTO

About Delineate

Delineate is building AI agents to design better clinical trials faster. This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential. We process existing clinical trial research into specialized datasets saving scientists months of effort. Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.

YC batch
W25 · Winter 2025
Status, per YC
Active
Category
AI, Developer tools
Team size
20
Location
Boston, MA, USA; Remote
Founded
2024
Checked
9h ago

YC tags: SaaS, Biotech, AI

Delineate in W25: 166 companies, 84% AI

LinkedIn

Delineate: questions

Which YC batch was Delineate in?

Delineate was in Y Combinator's Winter 2025 batch (W25).

Is Delineate still active?

Y Combinator lists Delineate as active.

Who founded Delineate?

Delineate's founders, as listed on its YC page: Emily Nieves (Founder/CEO), Jawad Iqbal (Founder/CTO).

Where is Delineate based?

Delineate lists Boston, MA, USA; Remote as its location on YC's directory.